David Levinson

DAVID LEVINSON is the President and CEO of iScribe, Inc. Prior to
founding iScribe in 1999, David Levison was President of Oncology
Therapeutics Network (OTN), a value-added distributor of oncology
pharmaceuticals and medical supplies to outpatient physicians.. OTN is
the leading supplier of products and services to medical oncologists
with 1998 shipments of $1.2 billion representing approximately a 55%
market share. OTN was a privately held, venture capital back firm prior
to being sold to Bristol-Myers Squibb in 1996. Mr. Levison also served
as the Chief Financial Officer for OTN’s parent company, Axion from 1990
to 1993. Prior to Axion, Mr. Levison was with the Cole Gilburne Fund, a
early stage, technology focused venture capital firm. Mr. Levison
received an M. S. from Williams College.